Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
4.000
+0.420 (11.73%)
At close: Jun 24, 2025, 4:00 PM
3.710
-0.290 (-7.25%)
Pre-market: Jun 25, 2025, 6:48 AM EDT

Synaptogenix Statistics

Total Valuation

Synaptogenix has a market cap or net worth of $5.56 million. The enterprise value is -$9.27 million.

Market Cap 5.56M
Enterprise Value -9.27M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025, after market close.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

Synaptogenix has 1.39 million shares outstanding. The number of shares has increased by 103.15% in one year.

Current Share Class 1.39M
Shares Outstanding 1.39M
Shares Change (YoY) +103.15%
Shares Change (QoQ) +2.62%
Owned by Insiders (%) 0.66%
Owned by Institutions (%) 7.41%
Float 1.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.08
P/TBV Ratio 1.08
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 72.71

Current Ratio 72.71
Quick Ratio 70.41
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -83.05% and return on invested capital (ROIC) is -26.38%.

Return on Equity (ROE) -83.05%
Return on Assets (ROA) -17.29%
Return on Invested Capital (ROIC) -26.38%
Return on Capital Employed (ROCE) -40.93%
Revenue Per Employee n/a
Profits Per Employee -$3.24M
Employee Count 4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -5.44% in the last 52 weeks. The beta is 1.30, so Synaptogenix's price volatility has been higher than the market average.

Beta (5Y) 1.30
52-Week Price Change -5.44%
50-Day Moving Average 2.73
200-Day Moving Average 2.91
Relative Strength Index (RSI) 57.14
Average Volume (20 Days) 2,580,543

Short Selling Information

The latest short interest is 11,273, so 0.81% of the outstanding shares have been sold short.

Short Interest 11,273
Short Previous Month 4,335
Short % of Shares Out 0.81%
Short % of Float 0.82%
Short Ratio (days to cover) 1.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -6.19M
Pretax Income -12.18M
Net Income -12.97M
EBITDA -6.18M
EBIT -6.19M
Earnings Per Share (EPS) -$9.90
Full Income Statement

Balance Sheet

The company has $14.83 million in cash and n/a in debt, giving a net cash position of $14.83 million or $10.67 per share.

Cash & Cash Equivalents 14.83M
Total Debt n/a
Net Cash 14.83M
Net Cash Per Share $10.67
Equity (Book Value) 6.45M
Book Value Per Share 3.72
Working Capital 15.11M
Full Balance Sheet

Cash Flow

Operating Cash Flow -5.05M
Capital Expenditures n/a
Free Cash Flow -5.05M
FCF Per Share -$3.64
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Synaptogenix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -103.15%
Shareholder Yield -103.15%
Earnings Yield -233.22%
FCF Yield -90.89%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date Apr 5, 2024
Split Type Reverse
Split Ratio 0.04:1

Scores

Altman Z-Score n/a
Piotroski F-Score 2